HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of recurrent high-grade endometrial stromal sarcoma controlled by a combination of Ifosfamide, adriamycin, and cisplatin].

Abstract
A 52-year-old woman with recurrent high-grade endometrial stromal sarcoma presented with left hypochondralgia. She had undergone total hysterectomy and bilateral salpingo-oophorectomy for the disease over the past six months, and preferred not to receive additional treatment. The following regimen of chemotherapy was given: each course consisted of ifosfamide (1,000 mg/m²) on days 1-5, adriamycin (60 mg/m²) on day 1, and cisplatin (15 mg/m²) on days 1-5. After 4 courses of the chemotherapy, the intraabdominal mass and multiple pulmonary nodules were reduced 45. 1% from the beginning. This case suggests that IAP might be effective chemotherapy for patients with high-grade endometrial stromal sarcoma.
AuthorsMichiyo Ushijima, Yoshihiro Yamakawa, Eriko Sakabe, Hiroki Waki, Kiyoshi Katou
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 37 Issue 10 Pg. 2003-5 (Oct 2010) ISSN: 0385-0684 [Print] Japan
PMID20948274 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Doxorubicin
  • Cisplatin
  • Ifosfamide
Topics
  • Abdominal Neoplasms (diagnostic imaging, drug therapy, secondary)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cisplatin (administration & dosage, therapeutic use)
  • Doxorubicin (administration & dosage, therapeutic use)
  • Endometrial Neoplasms (diagnostic imaging, drug therapy, pathology, surgery)
  • Female
  • Humans
  • Ifosfamide (administration & dosage, therapeutic use)
  • Lung Neoplasms (diagnostic imaging, drug therapy, secondary)
  • Middle Aged
  • Recurrence
  • Sarcoma, Endometrial Stromal (diagnostic imaging, drug therapy, pathology, surgery)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: